VELPANAT TABLET

VELPANAT TABLET

DESCRIPTION

  • Composition: Sofosbuvir and Velpatasvir
  • Manufacturer : Natco Pharma Ltd
  • Indication : Chronic hepatitis C virus (HCV) infection
  • Packaging : bottle of 28 tablets
  • Dosage Form : Tablet

PACKAGE

  • 400 Mg
  • 90 mg

Medicine Details
Brand name – Velpanat
Generic name – Sofosbuvir/Velpatasvir
Manufacturer – Natco Pharma Ltd
Salt composition – Sofosbuvir and Velpatasvir
Storage – Store at room temperature (10-30°C)
Dosage form – Oral (tablet)
Strength – 400mg + 100mg
Packaging – Bottle of 28 tablets
Gender – Unisex
Active ingredient – Sofosbuvir/Velpatasvir
Prescription required – Yes
Indication – Used in the treatment of chronic hepatitis C virus (HCV) infection

Description
Velpanat is a combination of two antivirals. It is used in the treatment of chronic hepatitis C virus infection. This combination of Sofosbuvir and Velpatasvir is known to be the first once-daily single-tablet treatment with pangenotypic activity. Velpanat (Sofosbuvir/Velpatasvir) works to fight against the virus in order to resolve the infection. Velpanat should be taken in the prescribed dose and duration. No alterations or manipulations should be done unless your healthcare provider tells you.

Pharmacodynamics
Velpanat is a combination of velpatasvir & sofosbuvir. Sofosbuvir is a nucleotide analog NS5B polymerase inhibitor and Velpatasvir is an NS5A replication complex inhibitor. Sofosbuvir is used in the treatment of genotype 1, 2, 3, and 4 HCV infection with different medicines, wherein duration depends on the HCV genotype. Velpatasvir is a novel NS5A inhibitor. It has potent in vitro anti-HCV activity across all genotypes at the picomolar level. The effect of Sofosbuvir (Velpanat) 400 mg (recommended dosage) and 1200 mg (three times the recommended dosage) on QTc interval was calculated in an active-controlled (moxifloxacin 400 mg) thorough QT trial. Sofosbuvir (Velpanat) does not prolong QTc to any clinically relevant extent, at a dose (three times the recommended dose). The effect of Velpatasvir (Velpanat) 500 mg (five times the recommended dosage) was calculated in an active-controlled (moxifloxacin 400 mg) thorough QT trial. Velpatasvir (Velpanat) does not prolong QTc interval to any clinically relevant extent, at a dose five times the recommended dose.

Ingredients
The active ingredient of Velpanat is Sofosbuvir/Velpatasvir.

Usage Of Medicine
Velpanat (Sofosbuvir/Velpatasvir) is used in the treatment of chronic hepatitis C virus (HCV) infection. Hepatitis C is an infection in the liver, which is caused by Hepatitis C Virus. Velpanat (Sofosbuvir/Velpatasvir) helps to control this infection.

Alternate Brands

  • Velpaclear Tablet
  • Sofocure-v Tablet
  • Sovihep V Tablet
  • Velasof Tablet
  • Resof total tablet

Side-Effects Of Velpanat Tablet

Common Side-Effects

  • Tiredness
  • Cough
  • Lower back pain
  • Skin rash
  • Headache
  • Nausea
  • Diarrhea
  • Muscle pain
  • Cramps
  • Loss of appetite
  • Serious Side-Effects
    Anemia
  • Insomnia
  • Blurred vision

Dosage

Take this medicine exactly as your healthcare provider tells you. Do not crush, chew or break the tablet. Swallow as a whole.

Missed Dose
Please consult your healthcare provider in case you miss a dose. Do not double the dose in order to cover up, unless your doctor tells you.

Overdose
Seek emergency medical support.

Warning And Precautions

  • Velpanat should be used with caution in patients with severe kidney disease.
  • Do not stop taking this medicine unless your healthcare provider tells you.
  • It is not yet known whether it is safe to consume alcohol with this medicine or not. Please consult your healthcare provider.
  • After taking this medicine, you may feel dizzy. If you experience such side effects, avoid driving and operating heavy machines.
  • Velpanat medicine is safe (only if prescribed) during breastfeeding. Make sure to tell your healthcare provider regarding all the side effects or changes you experience.

DESCRIPTION

  • Composition: Sofosbuvir and Velpatasvir
  • Manufacturer : Natco Pharma Ltd
  • Indication : Chronic hepatitis C virus (HCV) infection
  • Packaging : bottle of 28 tablets
  • Dosage Form : Tablet

PACKAGE

  • 400 Mg
  • 90 mg
Top
    wpChatIcon